Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
‘I am prepared’: Steve Spencer on becoming HIV positive in the era of PrEP and U=U

"I don’t like to use the term ‘PrEP failure’ which is thrown around in these cases, because PrEP is anything but that," Steve Spencer says.

Published
4 hours ago
From
Star Observer
'In complete shock': Sydney man contracts HIV despite taking PrEP drug

Steven Spencer, 27, tested positive for HIV in December, despite diligently using PrEP "on demand" before and after sexual encounters in line with the advice of doctors. "What happened to me doesn’t change the fact that PrEP is still the most powerful HIV preventative we have ever had," said Mr Spencer, one of the first men in Australia to start taking the medication more than five years ago.

Published
5 hours ago
From
Sydney Morning Herald
Rapidly Starting PrEP Before All Labs Are Back Proves Feasible in NYC

Waiting for all lab tests to return before prescribing Truvada resulted in a high dropout rate among those visiting sexual health clinics.

Published
21 March 2019
From
Poz
Getting on PrEP is harder than you think

In Louisiana, even informed patient Alexander Charles Adams got lost in barriers and stigma while trying to get a prescription for PrEP.

Published
21 March 2019
From
Whyy
PrEP Use Among Gay and Bi Men Hits a New High

A third of at-risk gay and bi men are now using Truvada for HIV prevention, the CDC says.

Published
21 March 2019
From
Poz
On-Demand PrEP With TDF/FTC Not Associated With Clinically Relevant Decline in Kidney Function

On-demand pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) is not associated with a significant relevant in kidney function, especially among young people with low pill use and high baseline estimated glomerular filtration rate, investigators in France found.

Published
20 March 2019
From
Contagion Live
Urine test can provide accurate point-of-care results about PrEP adherece

A point-of-care urine test can accurately determine if a person is adherent to tenofovir-based pre-exposure prophylaxis (PrEP), according to research presented to the recent Conference on Retroviruses

Published
19 March 2019
By
Michael Carter
LGBT+ health adviser urges Britain to make HIV-prevention drug free

Britain’s first national adviser for LGBT+ health has said the roll-out of a highly effective HIV prevention pill could save hundreds of thousands of pounds for the country’s publicly funded health authority. In an exclusive interview Michael Brady, who will take up the role on April 1, said a planned roll-out of pre-exposure prophylaxis (PrEP) - a once-daily pill that protects against HIV – in England would prove cost effective “very quickly”.

Published
18 March 2019
From
Reuters
Obituary: Mags Portman died on February 6th

The sexual-health pioneer and campaigner for access to PrEP was 44

Published
15 March 2019
From
The Economist (requires free registration)
Jean-Michel Molina, MD, on Biomedical Failures of PrEP: Rare, But Serious

"There are multiple reasons for PrEP failures and they could be at any point in the PrEP continuum of care. From people who may not use their pills as recommended, to a health care system that is not able to provide access to PrEP for people in need, it could be also the physicians who are not ready to prescribe PrEP or not aware that they could use PrEP for preventing HIV in high-risk patients. It could be also the test that we use sometimes that are not able to detect acute HIV infection. And, if you start PrEP in someone with acute HIV infection you will see more resistance."

Published
14 March 2019
From
Contagion Live
← First12345...160Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.